Duloxetine in the Treatment of Stress Urinary Incontinence.

Lilly

Status and phase: Completed; Phase 3

Conditions: Urinary Incontinence, Stress

Treatments: Drug: Duloxetine

Study type: Interventional

Funder types: Industry

Identifiers

NCT00191087

2686

F1J-MC-SBAU

Details and patient eligibility

About

The purpose of this study is to monitor the long term safety of duloxetine in the treatment of stress urinary incontinence.

Sex: Female

Ages: 18 to 75 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Women with predominant stress urinary incontinence.
• 7 or more incontinence episodes per week.

Exclusion criteria

• Use of monoamine inhibitors.

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)